tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Justin Zelin, 59 are a BUY (93.65%), 4 are a HOLD (6.35%).
Analyst Justin Zelin, currently employed at BTIG, carries an average stock price target met ratio of 21.35% that have a potential upside of 32.2% achieved within 97 days.
Justin Zelin’s has documented 112 price targets and ratings displayed on 24 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on IBRX, Immunitybio at 23-Jan-2026.
Analyst best performing recommendations are on ABEO (ABEONA THERAPEUTICS).
The best stock recommendation documented was for ABEO (ABEONA THERAPEUTICS) at 11/11/2020. The price target of $50 was fulfilled within 69 days with a profit of $17.5 (53.85%) receiving and performance score of 7.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Apr-2025
$19
$13.87 (270.37%)
$21
3 months 1 days ago
(12-Nov-2025)
0/2 (0%)
$14.06 (284.62%)
Buy Since 16-Oct-2017
$20
$14.87 (289.86%)
$20
4 months ago
(13-Oct-2025)
0/10 (0%)
$14.59 (269.69%)
Buy Since 02-Jun-2025
$20
$14.87 (289.86%)
$19
5 months 29 days ago
(15-Aug-2025)
0/2 (0%)
$12.87 (180.50%)
Buy Since 30-May-2024
$20
$14.87 (289.86%)
$21
8 months 28 days ago
(16-May-2025)
0/2 (0%)
$13.9 (227.87%)
Buy Since 19-Feb-2025
$15
$9.87 (192.40%)
$15
10 months 20 days ago
(24-Mar-2025)
0/2 (0%)
$9.88 (192.97%)
Which stock is Justin Zelin is most bullish on?
Which stock is Justin Zelin is most reserved on?
What Year was the first public recommendation made by Justin Zelin?
